HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey J Olson Selected Research

1- amino- 3- iodomethylene- cyclobutane- 1- carboxylic acid

2/2008Synthesis and evaluation of [123I] labeled iodovinyl amino acids syn-, anti-1-amino-3-[2-iodoethenyl]-cyclobutane-1-carboxylic acid, and 1-amino-3-iodomethylene-cyclobutane-1-carboxylic acid as potential SPECT brain tumor imaging agents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey J Olson Research Topics

Disease

75Neoplasms (Cancer)
06/2022 - 02/2002
49Glioblastoma (Glioblastoma Multiforme)
06/2022 - 10/2002
43Brain Neoplasms (Brain Tumor)
01/2022 - 02/2002
38Glioma (Gliomas)
10/2021 - 10/2002
11Gliosarcoma
06/2021 - 05/2002
9Necrosis
03/2022 - 01/2004
8Meningioma (Meningiomas)
10/2021 - 04/2014
7Astrocytoma (Pilocytic Astrocytoma)
11/2020 - 10/2002
6Medulloblastoma
01/2020 - 08/2005
5Hypoxia (Hypoxemia)
12/2012 - 12/2004
4Acoustic Neuroma (Acoustic Neurinoma)
12/2020 - 01/2018
4Neoplasm Metastasis (Metastasis)
01/2019 - 01/2010
4Seizures (Absence Seizure)
01/2019 - 01/2004
3Carcinoma (Carcinomatosis)
06/2021 - 04/2008
3Carcinogenesis
01/2018 - 12/2011
2Wounds and Injuries (Trauma)
01/2021 - 01/2004
2Edema (Dropsy)
01/2019 - 01/2010
2Oligodendroglioma
12/2015 - 04/2008
2Retinoblastoma (Glioblastoma, Retinal)
07/2004 - 10/2003
1Hemarthrosis
06/2021
1Venous Thromboembolism
06/2021
1Hemorrhage
06/2021
1Osteoarthritis
06/2021
1Compartment Syndromes
01/2021

Drug/Important Bio-Agent (IBA)

10Biomarkers (Surrogate Marker)IBA
06/2022 - 12/2006
9Temozolomide (Temodar)FDA LinkGeneric
11/2020 - 10/2002
9Amino AcidsFDA Link
11/2020 - 05/2002
9Proteins (Proteins, Gene)FDA Link
11/2020 - 01/2005
8AcidsIBA
01/2022 - 05/2002
8ErbB Receptors (EGF Receptor)IBA
01/2019 - 10/2003
7Bevacizumab (Avastin)FDA Link
06/2022 - 10/2016
7Biological ProductsIBA
11/2020 - 05/2002
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2019 - 01/2005
4Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA
06/2022 - 12/2016
4SteroidsIBA
01/2021 - 01/2010
4Histone Deacetylase InhibitorsIBA
03/2020 - 09/2012
4epidermal growth factor receptor VIIIIBA
12/2018 - 02/2009
4LigandsIBA
11/2011 - 05/2002
4Carboxylic AcidsIBA
04/2010 - 05/2002
3Carmustine (FIVB)FDA Link
11/2020 - 12/2008
3GadoliniumIBA
11/2020 - 07/2014
3DNA (Deoxyribonucleic Acid)IBA
07/2019 - 07/2010
3Anticonvulsants (Antiepileptic Drugs)IBA
01/2019 - 01/2010
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2019 - 01/2018
3PropionatesIBA
01/2015 - 05/2002
3Caspase 8 (Caspase-8)IBA
02/2012 - 06/2010
2belinostatIBA
01/2022 - 01/2019
2AndrogensIBA
06/2021 - 10/2020
2N-acetylaspartate (N-acetyl aspartate)IBA
11/2020 - 09/2012
2Therapeutic UsesIBA
01/2020 - 12/2004
2Adrenal Cortex Hormones (Corticosteroids)IBA
01/2019 - 01/2010
2Lapatinib (GW572016)FDA Link
01/2019 - 01/2018
2fluciclovine F-18IBA
07/2018 - 03/2009
2Protons (Proton)IBA
01/2018 - 01/2016
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2018 - 01/2016
2Hormones (Hormone)IBA
01/2018 - 06/2014
2Bortezomib (Velcade)FDA Link
10/2016 - 10/2010
2ParaffinIBA
01/2016 - 08/2005
2Formaldehyde (Formol)FDA Link
01/2016 - 08/2005
2Amino Acid Transport Systems (Amino Acid Transporter)IBA
01/2015 - 04/2010
2PolymersIBA
07/2014 - 12/2008
2UbiquitinIBA
06/2014 - 02/2012
2TOR Serine-Threonine KinasesIBA
09/2012 - 02/2012
21,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA
03/2012 - 07/2010
2lysyl- arginyl- alanyl- lysyl- alanyl- lysyl- threonyl- threonyl- lysyl- lysyl- arginine (PKCS)IBA
02/2012 - 07/2010
2MicroRNAs (MicroRNA)IBA
12/2011 - 07/2010
2ProteomeIBA
02/2007 - 12/2006
2Transcription Factors (Transcription Factor)IBA
12/2006 - 12/2004
1Cytotoxins (Cytolysins)IBA
06/2022
1ChloridesIBA
03/2022
1Rubidium-82IBA
03/2022
1PorphyrinsIBA
01/2022
1RNA (Ribonucleic Acid)IBA
01/2022
1AntigensIBA
01/2022
1protoporphyrin IXIBA
10/2021
1Insulin (Novolin)FDA Link
06/2021
1Warfarin (Coumadin)FDA LinkGeneric
06/2021
1Hematoxylin (Haematoxylon)IBA
03/2021
1Eosine Yellowish-(YS) (Eosin)IBA
03/2021
1TEA Domain Transcription FactorsIBA
01/2021
1Cadherins (E-Cadherin)IBA
01/2021
1Verteporfin (Visudyne)FDA Link
01/2021

Therapy/Procedure

40Therapeutics
06/2022 - 10/2002
35Radiotherapy
06/2022 - 02/2002
21Drug Therapy (Chemotherapy)
06/2022 - 08/2004
5Cytoreduction Surgical Procedures
06/2022 - 09/2008
5Immunotherapy
06/2022 - 08/2004
5Brachytherapy
11/2020 - 02/2002
4Adjuvant Radiotherapy
10/2021 - 01/2018
4Investigational Therapies (Experimental Therapy)
01/2019 - 05/2003
3Catheters
01/2004 - 02/2002
2Re-Irradiation
06/2022 - 07/2014
2Chemoradiotherapy
01/2020 - 01/2016
2Aftercare (After-Treatment)
01/2019 - 10/2002
2Retreatment
01/2018 - 01/2010
2Craniotomy
12/2015 - 07/2013
1Replacement Arthroplasty
06/2021
1External Fixators
01/2021
1Debridement
01/2021
1Resuscitation
01/2021